These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2950292)

  • 1. Regulatory decisions. Emphasis on safety issues.
    Strandberg K; Wiholm BE
    Med Toxicol; 1986; 1 Suppl 1():137-49. PubMed ID: 2950292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug utilization and morbidity statistics for the evaluation of drug safety in Sweden.
    Wiholm BE; Westerholm B
    Acta Med Scand Suppl; 1984; 683():107-17. PubMed ID: 6430038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study.
    Meijer WM; Cornel MC; Dolk H; de Walle HE; Armstrong NC; de Jong-van den Berg LT;
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):675-82. PubMed ID: 16761260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug related hospital admissions in subspecialities of internal medicine.
    Hallas J
    Dan Med Bull; 1996 Apr; 43(2):141-55. PubMed ID: 8741207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Under-reporting of serious adverse drug reactions in Sweden.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of spontaneous adverse drug reaction monitoring systems.
    Sachs RM; Bortnichak EA
    Am J Med; 1986 Nov; 81(5B):49-55. PubMed ID: 3789003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perception of prescription drug risks: a survey of patients with ankylosing spondylitis.
    O'Brien BJ; Elswood J; Calin A
    J Rheumatol; 1990 Apr; 17(4):503-7. PubMed ID: 2348431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory decisions and consumers.
    Rawlins MD
    Med Toxicol; 1986; 1 Suppl 1():128-9. PubMed ID: 3821428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nurses are increasingly involved in pharmacovigilance in Sweden.
    Ulfvarson J; Mejyr S; Bergman U
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoeconomics of adverse drug reactions.
    Lundkvist J; Jönsson B
    Fundam Clin Pharmacol; 2004 Jun; 18(3):275-80. PubMed ID: 15147278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paediatric adverse drug reaction reporting: understanding and future directions.
    Carleton BC; Smith MA; Gelin MN; Heathcote SC
    Can J Clin Pharmacol; 2007; 14(1):e45-57. PubMed ID: 17297195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The incidence of drug side effects with reference to organ systems. Experience of the spontaneous reporting system of the Swiss Drug Side Effect Center and Comprehensive Drug Monitoring].
    Kuhn M; Hartmann K; Maibach R; Capaul R; Gartmann JC
    Ther Umsch; 1993 Jan; 50(1):8-12. PubMed ID: 8378869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions in childhood: a review of prospective studies and safety alerts.
    Clavenna A; Bonati M
    Arch Dis Child; 2009 Sep; 94(9):724-8. PubMed ID: 19531524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of long-term care data systems. 20. Problems of data collection in long-term health care.
    Brooke EM
    Med Care; 1976 May; 14(5 Suppl):165-72. PubMed ID: 819734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.
    Cassels A; Hughes MA; Cole C; Mintzes B; Lexchin J; McCormack JP
    CMAJ; 2003 Apr; 168(9):1133-7. PubMed ID: 12719316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
    Blenkinsopp A; Wilkie P; Wang M; Routledge PA
    Br J Clin Pharmacol; 2007 Feb; 63(2):148-56. PubMed ID: 17274788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nationwide survey of subjectively reported adverse drug reactions in Sweden.
    Isacson D; Johansson L; Bingefors K
    Ann Pharmacother; 2008 Mar; 42(3):347-53. PubMed ID: 18303136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.